News Shortcuts from other journals

Drug eluting stents: risks of late restenosis sustained for up to three years

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39143.385012.BE (Published 08 March 2007) Cite this as: BMJ 2007;334:500

This article has a correction. Please see:

Two academic centres in the Netherlands and Switzerland have been routinely using drug eluting stents during percutaneous coronary interventions since 2002. When researchers looked at what happened to more than 8000 of their patients between 2002 and 2005, they found …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe